What is Biogen's other income (expense)?

Biogen (BIIB) reported other income (expense) of $3M in Q2 2026.

How has Biogen's other income (expense) changed year-over-year?

Biogen's other income (expense) increased by 190.9% year-over-year, from -$3.3M to $3M.

What is the long-term trend for Biogen's other income (expense)?

Over 4 years (2021 to 2025), Biogen's other income (expense) has grown at a -27.3% compound annual growth rate (CAGR), from -$1.1B to -$305.6M.

What does other income (expense) mean?

Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

Biogen BIIB Other Income (Expense)

Other Income (Expense) at other companies

Eli LillyLLY

-$65M+72.8%

Rogers CorporationROG

$1.1M+150%

TG TherapeuticsTGTX

-$14.43M-358%

Acadia PharmaceuticalsACAD

$542K-7.8%

AnaptysBio, Inc.ANAB

-$18.21M-55.0%

Syndax PharmaceuticalsSNDX

-$8.47M-678%

Other financials

Income statement

See full

Revenue$2.7B+3.4%

Gross profit$2.0B-4.0%

Operating income$610.7M—

Net income$97.5M-84.6%

EPS (diluted)$0.66-84.8%

Balance sheet

See full

Cash & equivalents$1.3B-53.4%

Total debt$7.6B+14.6%

Total equity$18.8B+6.9%

Total assets$32.1B+13.3%

Cash flow

See full

Operating cash flow$448.9M+179%

CapEx$40.9M+53.8%

Free cash flow$408.0M+204%

Valuation

See full

Market cap$30.36B+62.0%

Enterprise value$36.63B+62.2%

P/E34.4×+22.1×

P/S3×+1.2×

Profitability

See full

Gross margin74%-1.4pp

Operating margin22.9%—

Net margin8.8%-6.5pp

FCF margin26.9%+7.1pp

Returns & leverage

See full

Return on equity4.8%-4.3pp

Debt / equity0.4×0.0×

Current ratio1.9×-0.6×

Where this comes from

Reported directly by Biogen in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: Biogen’s 10-Q, filed July 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biogen's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Biogen's other income (expense)?: Biogen (BIIB) reported other income (expense) of $3M in Q2 2026.
How has Biogen's other income (expense) changed year-over-year?: Biogen's other income (expense) increased by 190.9% year-over-year, from -$3.3M to $3M.
What is the long-term trend for Biogen's other income (expense)?: Over 4 years (2021 to 2025), Biogen's other income (expense) has grown at a -27.3% compound annual growth rate (CAGR), from -$1.1B to -$305.6M.
What does other income (expense) mean?: Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.